Document Detail

Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
MedLine Citation:
PMID:  23065848     Owner:  NLM     Status:  Publisher    
Doxorubicin (DOX) was conjugated to polyethylenimine (PEI) in several synthetic ways and created PEI-succinic anhydride (SUC)-DOX, PEI-N-succinimidyl 3-maleimidopropionate (SMP)-DOX and PEI-3-maleimidopropionic acid hydrazide (MPH)-DOX conjugates using pH-insensitive linkage (amide bond) or pH-sensitive linkage (hydrazone bond). The effects of the conjugates on anticancer therapy against human breast cancer cells were investigated for in vitro release under different pH, cellular uptake, intracellular localization and antiproliferative activity. DOX release from PEI-MPH-DOX formed via hydrazone bonds occurred in an acid-triggered manner and increased with decreasing pH. But PEI-SUC-DOX and PEI-SMP-DOX formed via amide bonds were quite stable and released negligible DOX under both neutral and acidic conditions. The results from flow cytometry and confocal laser scanning microscopy analysis showed that conjugates uptakes were PEI-SUC-DOX > PEI-SMP-DOX > PEI-MPH-DOX, which was consistent with the primary amine content and more efficient than free DOX due to the intense nonspecific interaction between the positively charged conjugates and the negatively charged cell surface proteoglycans. PEI-MPH-DOX showed higher antiproliferative activity than that of PEI-SUC-DOX and PEI-SMP-DOX. The antiproliferative activity of PEI-MPH-DOX was achieved through the endocytosis, nuclear entry of released DOX and interaction with the DNA. However, PEI-SUC-DOX and PEI-SMP-DOX showed more endocytosis but less nuclear entry leading to lower antiproliferative activity. According to the measurements, we determined that enhanced endocytosis and pH-sensitive drug release were the critical processes in determining anticancer therapy of drug-polymer conjugate. The PEI-MPH-DOX conjugate could be sifted to use as a prodrug for cancer therapy and also as a novel delivery carrier to codelivery DOX and gene in further research. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
Da-Wen Dong; Shu-Wen Tong; Xian-Rong Qi
Related Documents :
11206078 - A single amino acid substitution affects substrate specificity in cysteine proteinases ...
22084898 - Site-specific incorporation of photocrosslinker and bioorthogonal amino acids into ente...
10498658 - Mutations in nonstructural protein 5a gene and response to interferon in hepatitis c vi...
8698498 - Amino acid residues in the pro region of escherichia coli heat-stable enterotoxin i tha...
2894408 - Increases in striatal and hippocampal impedance and extracellular levels of amino acids...
4068908 - Quantitative relationships between dietary linoleate and prostaglandin (eicosanoid) bio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-15
Journal Detail:
Title:  Journal of biomedical materials research. Part A     Volume:  -     ISSN:  1552-4965     ISO Abbreviation:  J Biomed Mater Res A     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101234237     Medline TA:  J Biomed Mater Res A     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interactio...
Next Document:  Spinal cord stimulation reduces hypersensitivity through activation of opioid receptors in a frequen...